VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MXLMaxLinear, Inc.
$96.60$8.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMXLFinancials

MaxLinear, Inc. (MXL) Financials

19Y historyFree accessUpdated daily

Despite a 43.0% year-over-year revenue recovery in 2026Q1, the company remains constrained by a -12.5% operating margin and a heavy $53.2 million quarterly R&D expenditure.

MXL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Sales/Revenue508.9M467.64M360.53M693.26M1.12B892.4M478.6M317.18M385M420.32M387.83M300.36M133.11M119.65M97.73M71.94M68.7M51.35M31.33M9.7M
Revenue Growth %40.89%29.71%-48%-38.12%25.53%86.46%50.89%-17.61%-8.4%8.38%29.12%125.64%11.25%22.43%35.85%4.71%33.79%63.9%223.13%-
Cost of Goods Sold218.97M201.83M168.11M310.48M482.44M420.19M289.33M172.58M208.35M241.73M157.84M144.94M51.15M45.58M37.02M26.62M21.56M17.05M12.68M4.9M
COGS % of Revenue-43.16%46.63%44.79%43.07%47.09%60.45%54.41%54.12%57.51%40.7%48.25%38.43%38.1%37.88%37%31.38%33.2%40.46%50.5%
Gross Profit289.93M265.81M192.42M382.78M637.81M472.2M189.26M144.6M176.65M178.59M229.99M155.42M81.96M74.06M60.71M45.32M47.14M34.3M18.66M4.8M
Gross Margin %56.97%56.84%53.37%55.21%56.93%52.91%39.55%45.59%45.88%42.49%59.3%51.75%61.57%61.9%62.12%63%68.62%66.8%59.54%49.5%
Gross Profit Growth %-38.15%-49.73%-39.99%35.07%149.49%30.89%-18.14%-1.08%-22.35%47.98%89.64%10.66%22%33.95%-3.86%37.43%83.87%288.67%-
Operating Expenses370.61M392.7M361.15M398.78M452.49M404.75M272.24M164.02M189.71M178.73M156.48M157.76M90.52M84.06M73.62M60.33M43.64M29.71M20.67M14.22M
OpEx % of Revenue-83.98%100.17%57.52%40.39%45.36%56.88%51.71%49.28%42.52%40.35%52.52%68%70.26%75.33%83.87%63.52%57.86%65.96%146.66%
Selling, General & Admin164.51M159.58M135.96M129.28M156.05M126.32M92.25M65.73M69.81M67M58.73M72.35M33.89M30.93M27.23M20.18M15.91M9.92M6.36M4.3M
SG&A % of Revenue-34.12%37.71%18.65%13.93%14.15%19.28%20.72%18.13%15.94%15.14%24.09%25.46%25.85%27.86%28.05%23.16%19.32%20.29%44.31%
Research & Development206.3M208.6M225.19M269.5M296.44M278.44M179.99M98.3M119.9M111.73M97.75M85.41M56.63M53.13M46.39M40.16M27.73M19.79M14.31M9.92M
R&D % of Revenue-44.61%62.46%38.87%26.46%31.2%37.61%30.99%31.14%26.58%25.2%28.43%42.54%44.41%47.47%55.82%40.36%38.54%45.67%102.35%
Other Operating Expenses-198K24.52M000000000000000000
Operating Income-81.16M-126.89M-168.74M-16M185.32M67.45M-82.98M-19.42M-13.06M-147K73.51M-2.33M-8.56M-10M-12.91M-15.01M3.5M4.59M-2.01M-9.42M
Operating Margin %-15.95%-27.13%-46.8%-2.31%16.54%7.56%-17.34%-6.12%-3.39%-0.03%18.95%-0.78%-6.43%-8.36%-13.21%-20.87%5.1%8.94%-6.42%-97.15%
Operating Income Growth %-24.8%-954.8%-108.63%174.75%181.29%-327.25%-48.69%-8785.03%-100.2%3250.92%72.74%14.42%22.53%14.02%-528.45%-23.69%328.46%78.66%-
EBITDA-50.15M-82.9M-122.58M46.64M257.22M151.86M-10.36M44.89M65.97M66.59M100.21M38.31M-3.45M-6.29M-9.38M-11.85M5.38M5.43M-1.4M-8.95M
EBITDA Margin %-9.85%-17.73%-34%6.73%22.96%17.02%-2.16%14.15%17.13%15.84%25.84%12.75%-2.59%-5.25%-9.59%-16.48%7.83%10.58%-4.48%-92.34%
EBITDA Growth %56.07%32.38%-362.84%-81.87%69.38%1565.93%-123.07%-31.94%-0.94%-33.55%161.6%1210.06%45.09%32.97%20.9%-320.46%-1.03%486.97%84.32%-
D&A (Non-Cash Add-back)31.01M43.99M46.15M62.63M71.9M84.41M72.62M64.31M79.03M66.74M26.7M40.64M5.11M3.71M3.53M3.16M1.87M841K606K467K
EBIT-84.34M-102.36M-227.84M-53.11M183.97M60.87M-101.9M-21.35M-18.6M-23.62M63.79M-42.81M-8.86M-12.35M-12.86M-14.96M3.77M4.61M-1.84M-8.63M
Net Interest Income-5.03M-6.67M-4.49M-4.65M-9.52M-12.92M-12.54M-10.36M-14.18M-10.1M468K175K221K218K229K223K297K-1K105K576K
Interest Income3.15M3.38M6.39M6.05M245K78K409K775K78K274K572K275K236K222K282K292K326K51K179K654K
Interest Expense5.36M10.06M10.87M10.7M9.77M13M12.95M11.13M14.26M10.38M104K100K15K4K53K69K29K52K74K78K
Other Income/Expense-29.38M-14M-69.98M-47.81M-11.12M-19.58M-31.88M-13.06M-19.79M-33.85M-9.82M-40.57M-187K-2.33M-3K-18K239K-33K96K711K
Pretax Income-110.54M-140.89M-238.72M-63.81M174.2M47.87M-114.85M-32.48M-32.85M-34M63.69M-42.91M-8.74M-12.33M-12.91M-15.03M3.74M4.56M-1.91M-8.71M
Pretax Margin %-21.72%-30.13%-66.21%-9.2%15.55%5.36%-24%-10.24%-8.53%-8.09%16.42%-14.28%-6.57%-10.31%-13.21%-20.89%5.45%8.88%-6.11%-89.82%
Income Tax21.56M-4.21M6.48M9.34M49.16M5.9M-16.26M-12.59M-6.65M-24.81M2.4M-575K-1.7M402K341K6.99M-6.37M230K078K
Effective Tax Rate %-19.5%2.99%-2.71%-14.63%28.22%12.33%14.16%38.75%20.25%72.98%3.77%1.34%19.49%-3.26%-2.64%-46.52%-170.21%5.04%0%-0.9%
Net Income-132.1M-136.68M-245.2M-73.15M125.04M41.97M-98.59M-19.9M-26.2M-9.19M61.29M-42.33M-7.04M-12.73M-13.25M-22.02M10.11M4.33M-1.91M-8.71M
Net Margin %-25.96%-29.23%-68.01%-10.55%11.16%4.7%-20.6%-6.27%-6.8%-2.19%15.8%-14.09%-5.29%-10.64%-13.56%-30.62%14.72%8.43%-6.11%-89.82%
Net Income Growth %40.65%44.26%-235.21%-158.5%197.93%142.57%-395.49%24.05%-185.17%-114.99%244.79%-501.21%44.7%3.92%39.83%-317.76%133.63%326.18%78.02%-
Net Income (Continuing)-132.1M-136.68M-245.2M-73.15M125.04M41.97M-98.59M-19.9M-26.2M-9.19M61.29M-42.33M-7.04M-12.73M-13.25M-22.02M10.11M4.33M-1.91M-8.71M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.51-1.58-2.93-0.911.550.53-1.35-0.28-0.38-0.140.91-0.79-0.19-0.37-0.40-0.680.300.06-0.19-0.76
EPS Growth %42.21%46.08%-221.98%-158.71%192.45%139.26%-382.14%26.32%-171.43%-115.38%215.19%-315.79%48.65%7.5%41.18%-326.67%400%131.58%75%-
EPS (Basic)--1.58-2.93-0.911.600.55-1.35-0.28-0.38-0.140.96-0.79-0.19-0.37-0.40-0.680.330.06-0.19-0.86
Diluted Shares Outstanding87.59M86.59M83.6M80.72M80.85M79.68M73.13M71M68.49M66.25M67.65M53.38M36.47M34.01M33.2M32.57M29.48M11.51M10.2M11.51M
Basic Shares Outstanding87.59M86.59M83.6M80.72M78.04M76.04M73.13M71M68.49M66.25M63.78M53.38M36.47M34.01M33.13M32.57M26.74M10.13M9.91M10.13M
Dividend Payout Ratio--------------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Persistent Operating Margin Deficit

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Recovery Amidst Cyclical Volatility

As reported in recent financial filings, MaxLinear's quarterly revenue has demonstrated a notable recovery, reaching $137.2 million in 2026Q1, which represents a 43.0% year-over-year growth rate, signaling a potential stabilization in end-market demand following the significant contraction observed throughout the 2024 fiscal year.

The recent acceleration in top-line performance suggests that the company is successfully navigating the inventory clearing phase that plagued the broadband segment. However, investors should monitor whether this growth is sustainable or merely a reflection of channel restocking, as the company remains highly sensitive to service provider CAPEX cycles.

Gross Margin Resilience Under Pressure

Based on the provided income statement data, MaxLinear has maintained a gross margin of 57.5% as of 2026Q1, demonstrating a structural ability to preserve pricing power despite the significant revenue fluctuations and the broader industry-wide challenges impacting the semiconductor manufacturing cost environment.

The stability of these margins suggests that the company's specialized mixed-signal IP continues to command a premium, even as volume-driven segments face headwinds. Maintaining this level of profitability is critical, as it provides the necessary gross profit dollars to support the company's heavy R&D investment requirements.

Operating Leverage Remains Severely Constrained

According to the latest quarterly results, MaxLinear continues to struggle with operating leverage, reporting a negative operating margin of -12.5% in 2026Q1, which indicates that the current revenue scale is insufficient to absorb the company's substantial fixed R&D and SG&A expenditure base.

The persistent gap between gross profit and operating expenses suggests that the company's cost structure is currently misaligned with its revenue run-rate. Unless the company can achieve a higher revenue ceiling, the path to operating profitability appears to be contingent on significant expense rationalization or a major product cycle inflection.

Stock-Based Compensation Impacts Earnings Quality

As indicated by the recent income statement data, MaxLinear's earnings quality is increasingly influenced by stock-based compensation, which reached $20.0 million in 2026Q1, further complicating the path to GAAP profitability and potentially diluting shareholder value during this period of sustained net income losses.

The emergence of significant stock-based compensation in recent quarters warrants careful investigation, as it may mask the true cash-burn profile of the business. Investors should monitor whether this compensation is tied to performance milestones that align with long-term margin expansion or if it represents a structural increase in operating costs.

Fixed Cost Burden Limits Flexibility

Based on the reported figures, MaxLinear's R&D spending remains a dominant cost driver, consistently exceeding $50 million per quarter, which highlights the company's commitment to maintaining its competitive edge in high-performance analog and RF design despite the ongoing lack of bottom-line profitability.

This heavy reliance on R&D investment suggests that management is prioritizing long-term technological relevance over short-term earnings. While this strategy may be necessary to compete in the PAM4 optical DSP market, it leaves the company vulnerable to cash flow volatility if revenue growth fails to materialize as expected.

MXL — Frequently Asked Questions

Quick answers to the most common questions about buying MXL stock.

What was MaxLinear, Inc.'s (MXL) revenue in 2025?

For fiscal year 2025, MaxLinear, Inc. (MXL) reported total revenue of $467.6M. This represents a 4723.0% increase compared to $9.7M in 2007.

Is MaxLinear, Inc. (MXL) profitable?

MaxLinear, Inc. (MXL) reported a net loss of $136.7M for the fiscal year ending 2025.

What is MaxLinear, Inc.'s operating profit margin?

MaxLinear, Inc. (MXL) reported an operating income of $-126.9M, resulting in an operating profit margin of -27.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is MaxLinear, Inc.'s gross profit and gross margin?

MaxLinear, Inc. (MXL) generated $265.8M in gross profit for the year, representing a gross profit margin of 56.8%. This demonstrates the company's core pricing power and production efficiency.